![]() |
||
The FDA Safety Alert warns that patients who are taking Avandia (rosiglitazone) - especially those who are known to have underlying heart disease or who are at high risk of heart attack (myocardial infarction) - should speak to their physicians regarding Avandia side effects and their continued use of Avanidia. The findings of a study, which will
appear in the June 14, 2007 issue of the New
England Journal of Medicine. In
this study researchers evaluated forty-two (42) separate studies comparing patients
using Avandia (rosiglitazone) to patients who were not using Avandia. This study
concludes that patients taking Avanida (rosiglitazone) face a 43% increased risk
of heart attack, and a 64% increased risk of dying from heart related ( cardiovascular)
disease. |
![]() |
|
Avandia Maker Sued Over Heart Attack “The widow and son of a Beaumont man are suing the maker of the popular diabetes drug Avandia, alleging it contributed to the man's death from a heart attack. Larry Alan Stanford, 60, died May 21, the same day a scientific analysis was published in the New England Journal of Medicine saying that Avandia was linked to a greater risk of heart attack and possibly death. His widow, Peggie Stanford, and son, Ryan Stanford, filed the lawsuit against GlaxoSmithKline PLC on Tuesday in U.S. District Court for the Eastern District of Texas.” Associated Press, Forbes 6/20/07 Diabetes
Drugs to Receive Strongest Warning Serious Side Effects |
||
|
|
||
Other Avandia Resources to check out:
|
||